BG101067A - Sterol derivatives used for meiosis regulation - Google Patents
Sterol derivatives used for meiosis regulationInfo
- Publication number
- BG101067A BG101067A BG101067A BG10106796A BG101067A BG 101067 A BG101067 A BG 101067A BG 101067 A BG101067 A BG 101067A BG 10106796 A BG10106796 A BG 10106796A BG 101067 A BG101067 A BG 101067A
- Authority
- BG
- Bulgaria
- Prior art keywords
- sterol derivatives
- derivatives used
- meiosis
- regulation
- sterols
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK75394 | 1994-06-23 | ||
| DK24195 | 1995-03-09 | ||
| PCT/DK1995/000265 WO1996000235A1 (en) | 1994-06-23 | 1995-06-23 | Sterol derivatives used for regulation of meiosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG101067A true BG101067A (en) | 1997-08-29 |
Family
ID=26063596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101067A BG101067A (en) | 1994-06-23 | 1996-12-18 | Sterol derivatives used for meiosis regulation |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5716777A (cs) |
| EP (1) | EP0767798B1 (cs) |
| JP (1) | JP3987105B2 (cs) |
| KR (1) | KR100408369B1 (cs) |
| CN (1) | CN1068333C (cs) |
| AT (1) | ATE248852T1 (cs) |
| AU (1) | AU694240B2 (cs) |
| BG (1) | BG101067A (cs) |
| BR (1) | BR9508074A (cs) |
| CA (1) | CA2192941C (cs) |
| CZ (1) | CZ289407B6 (cs) |
| DE (1) | DE69531682T2 (cs) |
| DK (1) | DK0767798T3 (cs) |
| ES (1) | ES2204955T3 (cs) |
| FI (1) | FI117159B (cs) |
| HU (1) | HUT76343A (cs) |
| IL (1) | IL114294A (cs) |
| IS (1) | IS4404A (cs) |
| MX (1) | MX9700174A (cs) |
| NO (1) | NO314534B1 (cs) |
| PL (1) | PL186688B1 (cs) |
| RU (1) | RU2194510C2 (cs) |
| SI (1) | SI9520077A (cs) |
| SK (1) | SK165596A3 (cs) |
| UA (1) | UA51622C2 (cs) |
| WO (1) | WO1996000235A1 (cs) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2214126A1 (en) * | 1995-03-06 | 1996-09-12 | Novo Nordisk A/S | Stimulation of meiosis |
| US6645953B2 (en) * | 1995-06-23 | 2003-11-11 | Novo Nordisk A/S | Meiosis regulating compounds |
| AU6122696A (en) * | 1995-06-23 | 1997-01-22 | Novo Nordisk A/S | Meiosis regulating compounds |
| CN1191543A (zh) * | 1995-06-23 | 1998-08-26 | 诺沃挪第克公司 | 减数分裂调控化合物 |
| JP2001506656A (ja) * | 1996-12-20 | 2001-05-22 | ノボ ノルディスク アクティーゼルスカブ | 減数分裂調節化合物 |
| US6177420B1 (en) * | 1997-05-16 | 2001-01-23 | Akzo Nobel N.V. | 20-aralkyl-5α-pregnane derivatives |
| JP2002502404A (ja) * | 1997-06-04 | 2002-01-22 | アクゾ・ノベル・エヌ・ベー | 減数分裂の調節のための17β−アリルオキシ(チオ)アルキル−アンドロスタン誘導体 |
| EP1042353B1 (en) * | 1997-12-18 | 2002-07-17 | Akzo Nobel N.V. | 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives |
| AU3701199A (en) * | 1998-05-13 | 1999-11-29 | Novo Nordisk A/S | Meiosis regulating compounds |
| IL139241A0 (en) | 1998-05-13 | 2001-11-25 | Novo Nordisk As | Meiosis regulating compounds |
| AU5408999A (en) * | 1998-05-26 | 1999-12-13 | Schering Aktiengesellschaft | Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound |
| EP1087988A1 (en) * | 1998-06-19 | 2001-04-04 | Novo Nordisk A/S | Meiosis regulating compounds |
| CA2352337A1 (en) * | 1998-12-11 | 2000-06-22 | Akzo Nobel Nv | 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity |
| WO2000036132A1 (en) * | 1998-12-14 | 2000-06-22 | Merck & Co., Inc. | Hiv integrase inhibitors |
| HUP0200280A2 (hu) * | 1999-02-10 | 2002-07-29 | Schering Ag. | Telítetlen kolesztánszármazékok és ezeket tartalmazó gyógyászati készítmények |
| AU2794000A (en) * | 1999-02-24 | 2000-09-14 | Novo Nordisk A/S | Treatment of infertility |
| CZ20012967A3 (cs) * | 1999-02-24 | 2001-12-12 | Novo Nordisk A/S | Léčení neplodnosti |
| HUP0200201A3 (en) * | 1999-02-26 | 2002-06-28 | Schering Ag | Meiosis activating sterol augments implantation rate |
| DE60000978T2 (de) * | 1999-03-09 | 2003-07-17 | Akzo Nobel N.V., Arnheim/Arnhem | 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose |
| ES2252048T3 (es) * | 1999-09-16 | 2006-05-16 | Novo Nordisk A/S | Composicion para fiv. |
| EP1127890A1 (en) | 2000-02-22 | 2001-08-29 | Schering Aktiengesellschaft | Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments |
| WO2001062260A2 (en) * | 2000-02-25 | 2001-08-30 | Schering Aktiengesellschaft | Improvement of implantation rate |
| WO2001062258A2 (en) * | 2000-02-25 | 2001-08-30 | Schering Aktiengesellschaft | Improvement of implantation rate using ff-mas |
| MXPA02011271A (es) * | 2000-05-18 | 2003-04-25 | Schering Ag | Fertilizacion de oocitos envejecidos. |
| EP1245572A1 (en) | 2001-03-26 | 2002-10-02 | Schering Aktiengesellschaft | Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
| AU2003203145A1 (en) * | 2002-02-22 | 2003-09-09 | Novo Nordisk A/S | A transducer of mas signalling |
| WO2012044817A2 (en) * | 2010-10-01 | 2012-04-05 | Indiana University Research And Technology Corporation | Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof |
| US9165822B2 (en) | 2013-03-11 | 2015-10-20 | Taiwan Semiconductor Manufacturing Company, Ltd. | Semiconductor devices and methods of forming same |
| EA024619B1 (ru) * | 2014-11-21 | 2016-10-31 | Эльвин Гаджи оглы Керимли | ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ |
-
1995
- 1995-05-23 US US08/448,217 patent/US5716777A/en not_active Expired - Fee Related
- 1995-06-23 SK SK1655-96A patent/SK165596A3/sk unknown
- 1995-06-23 MX MX9700174A patent/MX9700174A/es not_active IP Right Cessation
- 1995-06-23 CA CA002192941A patent/CA2192941C/en not_active Expired - Fee Related
- 1995-06-23 RU RU97101087/14A patent/RU2194510C2/ru not_active IP Right Cessation
- 1995-06-23 KR KR1019960707361A patent/KR100408369B1/ko not_active Expired - Fee Related
- 1995-06-23 HU HU9603584A patent/HUT76343A/hu not_active Application Discontinuation
- 1995-06-23 SI SI9520077A patent/SI9520077A/sl unknown
- 1995-06-23 BR BR9508074A patent/BR9508074A/pt not_active IP Right Cessation
- 1995-06-23 JP JP50272496A patent/JP3987105B2/ja not_active Expired - Lifetime
- 1995-06-23 UA UA96124771A patent/UA51622C2/uk unknown
- 1995-06-23 EP EP95922448A patent/EP0767798B1/en not_active Expired - Lifetime
- 1995-06-23 AU AU27343/95A patent/AU694240B2/en not_active Ceased
- 1995-06-23 ES ES95922448T patent/ES2204955T3/es not_active Expired - Lifetime
- 1995-06-23 AT AT95922448T patent/ATE248852T1/de not_active IP Right Cessation
- 1995-06-23 WO PCT/DK1995/000265 patent/WO1996000235A1/en not_active Ceased
- 1995-06-23 DK DK95922448T patent/DK0767798T3/da active
- 1995-06-23 PL PL95317830A patent/PL186688B1/pl not_active IP Right Cessation
- 1995-06-23 CN CN95193731A patent/CN1068333C/zh not_active Expired - Fee Related
- 1995-06-23 CZ CZ19963725A patent/CZ289407B6/cs not_active IP Right Cessation
- 1995-06-23 IL IL11429495A patent/IL114294A/en not_active IP Right Cessation
- 1995-06-23 DE DE69531682T patent/DE69531682T2/de not_active Expired - Fee Related
-
1996
- 1996-12-18 BG BG101067A patent/BG101067A/xx unknown
- 1996-12-20 FI FI965144A patent/FI117159B/fi active IP Right Grant
- 1996-12-20 NO NO19965516A patent/NO314534B1/no unknown
- 1996-12-23 IS IS4404A patent/IS4404A/is unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG101067A (en) | Sterol derivatives used for meiosis regulation | |
| IL130249A0 (en) | Meiosis regulating compounds | |
| GEP20012530B (en) | Neuroactive Steroids of the Androstane and Pregnane Series | |
| GR3034204T3 (en) | Lipopolyamines as transfection agents and pharmaceutical uses thereof | |
| DE69620241D1 (de) | Gonadotropin releasing hormon- antagonisten | |
| MD1616F2 (en) | Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment | |
| LV12438A (en) | Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof | |
| NZ325060A (en) | Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone | |
| DE69533991D1 (de) | Dipeptide, die die ausschüttung von wachstumshormonen stimulieren | |
| ATE293883T1 (de) | Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen | |
| MX9702308A (es) | Composiciones de esterol a partir de jabon de formacion de pulpa. | |
| IL118167A0 (en) | Pyrazolo (1,5a) pyrimidines their preparation and use | |
| NZ300942A (en) | 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists | |
| BG101875A (en) | New cryptoficins and method for their preparation | |
| PL314840A1 (en) | N-substituted derivatives of azabicycloheptane | |
| AU696230B2 (en) | N-substituted 3-azabicyclo (3.2.0)heptane derivatives, the preparation and use thereof | |
| NO20005667D0 (no) | Meioseregulerende forbindelser | |
| MX9803662A (es) | Oligopeptidos novedosos, preparacion y uso de estos. | |
| MX9800123A (es) | Compuestos que regulan la meiosis. | |
| PL311296A1 (en) | Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents | |
| BG102238A (en) | New imidazoline-2,4-dions of anticonvulsion effect containing, in the first place, orthosubstituted ar(alk)yl radical, and method for their preparation | |
| BR9713762A (pt) | Composto, uso dos mesmos, e, processo para regular a meiose em uma célula germinativa de mamìfero. | |
| UA10771A (uk) | Спосіб профілактики післяопераційhих ускладhеhь після екстракції катаракти з імплаhтацією кришталика | |
| MY129421A (en) | INHIBITORS OF p38 |